Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the ...

Health and Human Services Secretary Robert F. Kennedy Jr said that President Donald Trump calls him up “three or four times a week” to hound him with the same question. At such a critical moment in US ...

Cryotherapy, infant stem cells, extreme cold, IV infusions, red light therapy, blue light therapy … more Australians are ...

The Trump administration is launching a pressure campaign against prescription drugmakers in an effort to get them to lower ...

The shrinking ranks of "Dividend Knight" contenders. Healthcare stocks with hard times but high yields. What investors should ...

The Londonderry Township board of supervisors has postponed the decision on changing zoning rules to allow an AI data center ...

CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...

Weight loss medications such as Wegovy and Zepbound have garnered an enormous amount of attention recently for their ability to help some users lose significant amounts of weight relatively easily.

The Senate nixed a provision to “delink” drug list prices from compensation for PBMs and other drug middlemen days before its ...